about
Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscleAdipose triglyceride lipase regulation of skeletal muscle lipid metabolism and insulin responsivenessActivating HSP72 in rodent skeletal muscle increases mitochondrial number and oxidative capacity and decreases insulin resistance.Reactive oxygen species enhance insulin sensitivityPLIN5 deletion remodels intracellular lipid composition and causes insulin resistance in muscle.Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.Disruption of the Class IIa HDAC Corepressor Complex Increases Energy Expenditure and Lipid Oxidation.Plasma sphingosine-1-phosphate is elevated in obesityEvaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy.PKR is not obligatory for high-fat diet-induced obesity and its associated metabolic and inflammatory complications.Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance.Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide.Skeletal muscle-specific overproduction of constitutively activated c-Jun N-terminal kinase (JNK) induces insulin resistance in miceReversing diet-induced metabolic dysregulation by diet switching leads to altered hepatic de novo lipogenesis and glycerolipid synthesis.Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance.Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in miceLipid and insulin infusion-induced skeletal muscle insulin resistance is likely due to metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylationα-Melanocyte stimulating hormone promotes muscle glucose uptake via melanocortin 5 receptors.AMP-activated protein kinase and muscle insulin resistance.Fatty acid metabolism, energy expenditure and insulin resistance in muscle.The regulation of glucose metabolism: implications and considerations for the assessment of glucose homeostasis in rodents.Does maternal-fetal transfer of creatine occur in pregnant sheep?Analysis of Mammalian Cell Proliferation and Macromolecule Synthesis Using Deuterated Water and Gas Chromatography-Mass Spectrometry.ATGL-mediated triglyceride turnover and the regulation of mitochondrial capacity in skeletal muscle.The CDP-Ethanolamine Pathway Regulates Skeletal Muscle Diacylglycerol Content and Mitochondrial Biogenesis without Altering Insulin Sensitivity.Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance.Overexpression of sphingosine kinase 1 in liver reduces triglyceride content in mice fed a low but not high-fat diet.Increased liver AGEs induce hepatic injury mediated through an OST48 pathway.Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status.Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion.IκB kinase β (IKKβ) does not mediate feedback inhibition of the insulin signalling cascade.No need to sweat: is dieting enough to alleviate insulin resistance in obesity?Interaction of diet and training on endurance performance in rats.Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with Type 2 diabetes.Regulation of fuel metabolism by preexercise muscle glycogen content and exercise intensity.Alpha2-AMPK activity is not essential for an increase in fatty acid oxidation during low-intensity exercise.AMP kinase activation with AICAR further increases fatty acid oxidation and blunts triacylglycerol hydrolysis in contracting rat soleus muscle.PGC-1alpha gene expression is down-regulated by Akt- mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle.Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content.Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha.
P50
Q22241966-3EF9581D-984F-4BB6-9896-D3C4BD42AC31Q33642894-F61B6634-FA40-4BE1-ADC6-B70664398A4EQ33646728-A4E00254-BC98-4E48-8B66-67BCD7E87355Q33941647-DA601DF9-5FE0-4DB2-B895-9146737C284EQ34080551-77ADEE69-12F3-443F-833B-7B57BEF0CB35Q34358476-E9CA2CEB-E13C-4C3A-A19D-C6F61E8CC8E3Q34540285-500C605E-4CD9-41D9-89DA-4D86DFB1CF71Q34988407-183F6EF7-6E00-49B0-9594-F8008BB91814Q36363858-C2E5AC43-D355-4C59-B413-333A07269034Q36549536-F426FDB7-4C92-4EF5-8612-2551F403FD5DQ36560514-87A43198-54AF-43A4-B777-12BE5028762FQ36623114-7E61E617-44E8-4110-ACE2-D0CE255F99E7Q36664514-DD8B49E0-36C2-4B77-80DF-0D12801D3527Q36974279-F3FBCDA3-512C-4594-833D-AEC92D3FC371Q37105295-956AD496-BCF2-4CD7-9FDC-01510489E034Q37110553-2580D189-06B2-448A-909C-E49E0CB93DC5Q37264198-6962F3A5-F40C-468D-9806-224444C996DBQ37278856-0601ADBC-35FC-475F-9D9D-EAAF79C0F1D4Q37410660-09905B30-8ED4-487C-8D88-FC62F2973B4DQ38170079-91D2CA26-6A07-44C0-9B5C-0CA5AD9A5AB8Q38247935-D8AFC445-FC74-49DB-A7D2-1E5A87E350FFQ39141658-6F51F2E1-F0E1-4973-B73A-E2FD7A826AE3Q39277859-F3CE8DF2-C5B4-4FC6-89E6-9D61D320865DQ41102976-A4CAE98F-C689-44DF-945A-928C79568B0FQ41248517-E35F8C01-0547-43DB-90AF-3CFCBDF2932FQ41299746-973CE9A4-295C-44E4-A3C3-8426757ED765Q41711486-5B4D472E-AE84-4392-AF1E-E138516E0159Q42061964-979EAFE2-B2CA-4847-A778-EED83F596622Q42452350-FEF85456-438C-4C41-B97D-0A5CE6C3B67AQ42492116-F28E57D3-ABFB-4F9A-B74C-7258F6763F93Q42799107-CB59A6C4-38F6-469E-98E1-B787A31B5BA2Q43251063-08817B0E-792D-48E1-A1E2-CFD8B02BD4C5Q43668623-D35D0293-94CA-4EA6-90A7-2039345B1187Q44691839-AA871ED3-8A24-4F42-AA6E-A6C551B5B7D1Q45001527-C0E64C3D-9CD5-4D10-B3EC-32D4EC167F38Q46305236-70C8658D-7841-44F9-ACD5-45AEE440CC11Q46387221-DBB07A88-2180-4E38-B976-93BD204885D1Q46735110-47831EFF-1097-4615-B708-1CC8EAE7EA61Q46933158-1AAA44EA-F604-424B-A778-705718BFDE86Q47586381-2991538B-F9AC-4939-BC74-F372BA8C0EE7
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Clinton R. Bruce
@ast
Clinton R. Bruce
@en
Clinton R. Bruce
@es
Clinton R. Bruce
@nl
Clinton R. Bruce
@sl
type
label
Clinton R. Bruce
@ast
Clinton R. Bruce
@en
Clinton R. Bruce
@es
Clinton R. Bruce
@nl
Clinton R. Bruce
@sl
prefLabel
Clinton R. Bruce
@ast
Clinton R. Bruce
@en
Clinton R. Bruce
@es
Clinton R. Bruce
@nl
Clinton R. Bruce
@sl
P106
P1153
35331748200
P31
P496
0000-0002-0515-3343